Quality of life after treatment of laryngeal carcinoma: A single centre cross-sectional study

Annals of the Royal College of Surgeons of England

Volumn 93, Issue 8, 2011, Pages 591-595

  Williamson, J S ^a   Ingrams, D ^a   Jones, H ^b  

^a ROYAL GWENT HOSPITAL   (United Kingdom)

^b ROYAL GLAMORGAN HOSPITAL   (United Kingdom)

Author keywords

Head and neck neoplasm; University washington quality of life

Indexed keywords

AGE; AGED; ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; LARYNX TUMOR; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; SQUAMOUS CELL CARCINOMA; TIME; TREATMENT OUTCOME;

AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; QUALITY OF LIFE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84555203669     PISSN: 00358843     EISSN: None     Source Type: Journal    
DOI: 10.1308/147870811X13137608455253     Document Type: Article

References (27)

1. Owen C, Watkinson JC, Pracy P, Glaholm J. The psychosocial impact of head and neck cancer. Clin Otolaryngol Allied Sci 2001; 26: 351-356.
2. Terrell JE, Nanavati K, Esclamando RM et al. health impact of head and neck cancer. Otolaryngol Head Neck Surg 1999; 120: 852-859.
3. Braz DS, Ribas MM, Dedivitis RA et al. Quality of life and depression in patients undergoing total and partial laryngectomy. Clinics 2005; 60: 135-142.
4. Morton RP. Studies in the quality of life of head and neck cancer patients: results of a two-year longitudinal study and a comparative cross-sectional cross-cultural survey. Laryngoscope 2003; 113: 1,091-1,103.
5. Bjordal K, Ahlner-Elmqvist M, Hammerlid E et al. A prospective study of quality of life in head and neck cancer patients. Part II: longitudinal data. Laryngoscope 2001; 111: 1,440-1,452.
6. LoTempio MM, Wang KH, Sadeghi A et al. Comparison of quality of life outcomes in laryngeal cancer patients following chemoradiation vs total laryngectomy. Otolaryngol Head Neck Surg 2005; 132: 948-953.
7. Kazi R, Prasad V, Venkitaraman R et al. Questionnaire analysis of the swallowing-related outcomes following total laryngectomy. Clin Otolaryngol 2006; 31: 525-530.
8. Kazi R, De Cordova J, Kanagalingam J et al. Quality of life following total laryngectomy: assessment using the UW-QOL scale. J Otorhinolaryngol Relat Spec 2007; 69: 100-106.
9. Deleyiannis FW, Weymuller EA, Coltera MD, Futran N. Quality of life after laryngectomy: are functional disabilities important? Head Neck 1999; 21: 319-324.
10. Stoeckli SJ, Guidicelli M, Schneider A et al. Quality of life after treatment for early laryngeal carcinoma. Eur Arch Otorhinolaryngol 2001; 258: 96-99.
11. Weymuller EA, Alsarraf R, Yueh B et al. Analysis of the performance characteristics of the University of Washington Quality of Life instrument and its modification (UW-QOL-R). Arch Otolaryngol Head Neck Surg 2001; 127: 489-493.
12. Deleyiannis FW, Weymuller EA, Coltrera MD. Quality of life of disease-free survivors of advanced (stage III or IV) oropharyngeal cancer. Head Neck 1997; 19: 466-473.
13. Edwards DM, Jones J. Incidence of and survival from upper aerodigestive tract cancers in the UK: the influence of deprivation. Eur J Cancer 1999; 35: 968-972.
14. Conway DI, McKinney PA, McMahon AD et al. Socioeconomic factors associated with risk of upper aerodigestive tract cancer in Europe. Eur J Cancer 2010; 46: 588-598.
15. National Institute for Clinical Excellence. Improving Outcomes in Head and Neck Cancers: The Manual. London: NICE; 2004.
16. Khafif A, Posen J, Yagil Y et al. Quality of life in patients older than 75 years following major head and neck surgery. Head Neck 2007; 29: 932-939.
17. El-Deiry MW, Futran ND, McDowell JA et al. Influences and predictors of long-term quality of life in head and neck cancer survivors. Arch Otolaryngol Head Neck Surg 2009; 135: 380-384.
18. Aarstad HJ, Aarstad AK, Heimdal JH, Olofsson J. Mood, anxiety and sense of humor in head and neck cancer patients in relation to disease stage, prognosis and quality of life. Acta Otolaryngol 2005; 125: 557-565.
19. Gourin CJ, Boyce BJ, Vaught CC et al. Effect of comorbidity on post-treatment quality of life scores in patients with head and neck squamous cell carcinoma. Laryngoscope 2009; 119: 907-914.
20. Trivedi NP, Swaminathan DK, Thankappan K et al. Comparison of quality of life in advanced laryngeal cancer patients after concurrent chemoradiotherapy vs total laryngectomy. Otolaryngol Head Neck Surg 2008; 139: 702-707.
21. Boscolo-Rizzo P, Maronato F, Marchiori C et al. Long-term quality of life after total laryngectomy and postoperative radiotherapy versus concurrent chemoradiotherapy for laryngeal preservation. Laryngoscope 2008; 118: 300-306.
22. Kahn ST, Johnstone PA. Management of xerostomia related to radiotherapy for head and neck cancer. Oncology 2005; 19: 1,827-1,832.
23. Tobias JS, Monson K, Gupta N et al. Chemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK head and Neck (UKhAN1) trial. Lancet Oncol 2010; 11: 66-74.
24. Jensen SB, Pedersen AM, Vissink A et al. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact. Support Care Cancer 2010; 18: 1,061-1,079.
25. Licitra L, Bergamini C, Mirabile A, Granata R. Targeted therapy in head and neck cancer. Curr Opin Otolaryngol Head Neck Surg 2011; 19: 132-137.
26. Hamid OA, El Fiky LM, Medani MM et al. Laryngeal cancer in Egypt: quality of life measurement with different treatment modalities. Head Neck 2011; 33: 1,162-1,169.
27. Vartanian JG, Kowalski LP. Acceptance of major surgical procedures and quality of life among long-term survivors of advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 2009; 135: 376-379.